Okklo Life Sciences Overview
- Year Founded
-
2011
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
- Investors
-
2
Okklo Life Sciences General Information
Description
Developer of novel therapeutic solutions using cyclodextrin-based technologies designed to treat neglected and orphan diseases. The company's novel therapeutic solutions can be applied to a multitude of molecular targets, enabling patients to improve their quality of life.
Contact Information
Website
www.okklo.comCorporate Office
- Kloosterstraat 9
- 6534 AT Nijmegen
- Netherlands
Corporate Office
- Kloosterstraat 9
- 6534 AT Nijmegen
- Netherlands
Okklo Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Oct-2022 | Completed | Out of Business | |||
| 3. Debt - General | 14-May-2016 | Completed | Generating Revenue | |||
| 2. Grant | 15-May-2014 | Completed | Product Development | |||
| 1. Grant | 01-Apr-2012 | Completed | Product Development |
Okklo Life Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Okklo Life Sciences Patents
Okklo Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2017188820-A1 | Cyclodextrins as procoagulants | Inactive | 29-Apr-2016 |
Okklo Life Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Okklo Life Sciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Netherlands Organization for Scientific Research | Government | |||
| Rijksdienst voor Ondernemend Nederland | Government |
Okklo Life Sciences Investments (1)
Okklo Life Sciences’s most recent deal was a Joint Venture with Alveron Pharma. The deal was made on 01-Mar-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Alveron Pharma | 01-Mar-2019 | Joint Venture | Biotechnology |
Okklo Life Sciences FAQs
-
When was Okklo Life Sciences founded?
Okklo Life Sciences was founded in 2011.
-
Where is Okklo Life Sciences headquartered?
Okklo Life Sciences is headquartered in Nijmegen, Netherlands.
-
What is the size of Okklo Life Sciences?
Okklo Life Sciences has 3 total employees.
-
What industry is Okklo Life Sciences in?
Okklo Life Sciences’s primary industry is Therapeutic Devices.
-
Is Okklo Life Sciences a private or public company?
Okklo Life Sciences is a Private company.
-
What is Okklo Life Sciences’s current revenue?
The current revenue for Okklo Life Sciences is .
-
Who are Okklo Life Sciences’s investors?
Netherlands Organization for Scientific Research and Rijksdienst voor Ondernemend Nederland have invested in Okklo Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
